The Eve Appeal has announced that UCLH Cancer Collaborative hase launched the first pilot project of an NHS ovarian cancer surveillance service for women who carry a faulty BRCA gene and have chosen not to have their ovaries and fallopian tubes removed. The pilot, known as the ALDO project (Avoiding Late Diagnosis in Ovarian Cancer), aims to recruit 2,000 women aged over 35 from across England and will use a blood test as part of an NHS service to detect ovarian cancer amongst BRCA-carriers before they have any symptoms.

This is the first time that this technology has been piloted as an NHS service and heralds a significant step towards meeting the recommendations in the National Cancer Strategy to improve early diagnosis.

eveappeal.org.uk
@eveappeal